Weight gain in women diagnosed with breast cancer.

This review of the literature indicates that weight gain is a common observation among women after the diagnosis of breast cancer. Gains in weight range from 0 to 50 lb and are influenced by menopausal status; nodal status; and the type, duration, and intensity of treatment. Weight gain appears to be greater among premenopausal women; among those who are node positive; and among those receiving higher dose, longer duration, and multiagent regimens. Psychosocial research suggests that weight gain has a profoundly negative impact on quality of life in patients with breast cancer. Recent findings also suggest that weight gain during therapy may increase the risk of recurrence and decrease survival. Although weight gain in patients with breast cancer is clinically well appreciated, little research has been conducted to investigate the underlying mechanisms of energy imbalance. Changes in rates of metabolism, physical activity, and dietary intake are all plausible mechanisms and call for more research. Further study will provide valuable insight into the problem of weight gain and encourage effective interventions to improve the quality and quantity of life for the woman with breast cancer. Until more is known, however, dietetics practitioners will have to monitor and work individually with patients with breast cancer and use empirical approaches to achieve the important goal of weight management.

[1]  R. Senie,et al.  Obesity at Diagnosis of Breast Carcinoma Influences Duration of Disease-free Survival , 1992, Annals of Internal Medicine.

[2]  I. Feurer,et al.  Energy Expenditure in Malnourished Cancer Patients , 1983, Annals of surgery.

[3]  E. Winer,et al.  Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy. , 1997, The American journal of clinical nutrition.

[4]  B. Meyerowitz,et al.  Adjuvant chemotherapy for breast carcinoma: Psychosocial implications , 1979, Cancer.

[5]  D. Schaid,et al.  Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis , 1991, Cancer.

[6]  D. Ota,et al.  Obesity, non‐protein‐bound estradiol levels, and distribution of estradiol in the sera of breast cancer patients , 1986, Cancer.

[7]  A. Hart,et al.  Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk. , 1985, British Journal of Cancer.

[8]  M. K. Knobf,et al.  Weight gain in women with breast cancer receiving adjuvant chemotherapy. , 1983, Oncology nursing forum.

[9]  G. Schneider,et al.  Obesity, androgens, estrogens, and cancer risk. , 1982, Cancer research.

[10]  L. H. Maurer,et al.  Psychosocial aspects of neoplastic disease: I. Functional status of breast cancer patients during different treatment regimens. , 1980, The American journal of psychiatry.

[11]  S. Gundersen,et al.  Cyclical Use of Tamoxifen and High-Dose Medroxyprogesterone Acetate in Advanced Breast Cancer , 1987 .

[12]  A. Kristal,et al.  Weight loss in women participating in a randomized trial of low-fat diets. , 1991, The American journal of clinical nutrition.

[13]  C. Redmond,et al.  A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. , 1989, The New England journal of medicine.

[14]  Morgan Lr Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients. , 1985 .

[15]  J. Crave,et al.  Pathophysiology of sex hormone binding globulin (SHBG): Relation to insulin , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[16]  H. Parnes,et al.  Appetite stimulation and weight gain with megestrol acetate. , 1990, Seminars in oncology.

[17]  Dixon Jk,et al.  Breast cancer and weight gain: an unexpected finding. , 1978 .

[18]  P. Tartter,et al.  Cholesterol and obesity as prognostic factors in breast cancer , 1981, Cancer.

[19]  E. Winer,et al.  Why women gain weight with adjuvant chemotherapy for breast cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  T. Brewin CAN A TUMOUR CAUSE THE SAME APPETITE PERVERSION OR TASTE CHANGE AS A PREGNANCY? , 1980, The Lancet.

[21]  T M Therneau,et al.  Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  P. Newberne,et al.  Dietary lipids and immune function. , 1992, The Journal of nutrition.

[23]  R. Prentice,et al.  Results of a randomized feasibility study of a low-fat diet. , 1990, Archives of internal medicine.

[24]  R. Elashoff,et al.  Unpublished Data Summaries and the design and conduct of clinical trials. The Nutrition Adjuvant Study experience and commentary. , 1989, Controlled clinical trials.

[25]  P. Taylor,et al.  Association of change in body mass with breast cancer. , 1990, Cancer research.

[26]  S. Hilsenbeck,et al.  Clinical trial of high‐dose oral medroxyprogesterone acetate in the treatment of metastatic breast cancer and review of the literature , 1988, Cancer.

[27]  L. Holm,et al.  Dietary intervention in breast cancer patients: effects on dietary habits and nutrient intake. , 1990, European journal of clinical nutrition.

[28]  M. Szklo,et al.  Estrogen receptors and breast cancer. , 1986, Epidemiologic reviews.

[29]  D. Lees,et al.  Resting Energy Expenditure in Controls and Cancer Patients with Localized and Diffuse Disease , 1984, Annals of surgery.

[30]  P. Sorlie,et al.  Mortality Effects of Community Socioeconomic Status , 1997, Epidemiology.

[31]  Glatt Mm,et al.  Letter: Scientific medicine. , 1974 .

[32]  D. Albanes,et al.  Validation and Comparison of Eight Physical Activity Questionnaires , 1990, Epidemiology.

[33]  J. Abrams,et al.  Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  A. Tannenbaum Relationship of body weight to cancer incidence. , 1940 .

[35]  A. Rimm,et al.  The association of body weight with recurrent cancer of the breast , 1978, Cancer.

[36]  H. Takei,et al.  Oral high-dose medroxyprogesterone acetate treatment for recurrent breast cancer. , 1995, Anticancer research.

[37]  E. Wynder,et al.  Epidemiology and natural history of breast cancer. Implications for the body weight-breast cancer controversy. , 1990, The Surgical clinics of North America.

[38]  L. Kuller Eating fat or being fat and risk of cardiovascular disease and cancer among women. , 1994, Annals of epidemiology.

[39]  L. Sachs,et al.  Nutritional concerns of women with breast cancer. , 1993, Journal of cancer education : the official journal of the American Association for Cancer Education.

[40]  J. K. Martin,et al.  Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  M. Knobf Symptoms and rehabilitation needs of patients with early stage breast cancer during primary therapy , 1990, Cancer.

[42]  R. Verreault,et al.  Body weight and prognostic indicators in breast cancer. Modifying effect of estrogen receptors. , 1989, American journal of epidemiology.

[43]  C. Spurr,et al.  High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  G. Colditz Fat, estrogens, and the time frame for prevention of breast cancer. , 1995, Epidemiology.

[45]  R. Jeffery,et al.  Diet intervention methods to reduce fat intake: nutrient and food group composition of self-selected low-fat diets. , 1990, Journal of the American Dietetic Association.

[46]  E. Wynder,et al.  Clinical trials of dietary interventions to enhance cancer survival. , 1990, Progress in clinical and biological research.

[47]  M. Huntington,et al.  Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast , 1985, Cancer.

[48]  G. Lyman,et al.  Obesity, body fat distribution, and sex hormones in breast cancer patients , 1991, Cancer.

[49]  L. Holm,et al.  Dietary intervention in breast cancer patients: effects on food choice. , 1992, European journal of clinical nutrition.

[50]  W. D. Selles,et al.  Changes in food patterns during a low-fat dietary intervention in women. , 1990, Journal of the American Dietetic Association.

[51]  Stephen E. Jones,et al.  Adjuvant Therapy of Cancer , 1990 .

[52]  G. Evans,et al.  Weight changes in women with metastatic breast cancer treated with megestrol acetate: a comparison of standard versus high-dose therapy. , 1990, Seminars in oncology.

[53]  J. Carpenter,et al.  Weight gain with breast cancer adjuvant treatment , 1991, Cancer.

[54]  R. Klein,et al.  Association of dietary and life-style factors with sex hormones in postmenopausal women. , 1995, Epidemiology.

[55]  H. Bingham Obesity and breast disease , 1990 .

[56]  M. Kimura,et al.  Biological characteristics of breast cancer in obesity. , 1976, The Tohoku journal of experimental medicine.

[57]  R. Jeffery,et al.  Is obesity due to overeating and inactivity, or to a defective metabolic rate? A review , 1991 .

[58]  C. Grindel,et al.  Food intake of women with breast cancer during their first six month of chemotherapy. , 1989, Oncology nursing forum.

[59]  P. Wingo,et al.  Cancer statistics, 1995 , 1995, CA: a cancer journal for clinicians.

[60]  R. Prentice,et al.  Dietary fat reduction and plasma estradiol concentration in healthy postmenopausal women. The Women's Health Trial Study Group. , 1990, Journal of the National Cancer Institute.

[61]  L. Ottestad,et al.  The effect of pre-morbid height and weight on the survival of breast cancer patients. , 1990, British Journal of Cancer.

[62]  C. Enriori,et al.  Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss. , 1986, Gynecologic oncology.

[63]  D. Ingram,et al.  Obesity and breast disease. The role of the female sex hormones , 1989, Cancer.

[64]  E. Wynder,et al.  Breast cancer--the optimal diet. , 1992, Advances in experimental medicine and biology.

[65]  J. Poortman,et al.  Relationship of weight to the promotion of breast cancer after menopause. , 1981, Nutrition and cancer.

[66]  Foltz At Weight gain among stage II breast cancer patients: a study of five factors. , 1985 .